Gonorrhoea: To screen or not to screen?

Sexually Transmitted Infections

Volumn 86, Issue 6, 2010, Pages 411-412

  Ross, Jonathan D C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST; EDITORIAL; GONORRHEA; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; QUALITY CONTROL; SCREENING; SENSITIVITY AND SPECIFICITY;

EARLY DIAGNOSIS; FEMALE; GONORRHEA; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 78449239622     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2010.042804     Document Type: Editorial

References (15)

1. Health Protection Agency. All new STI episodes seen at GUM clinics in the UK: 1999-2008, 2009. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1215589015024 (accessed 12 Feb 2010).
2. Pittrof R, Hitchings S, FitzGerald M. Questioning the value of screening for gonorrhoea in symptomless heterosexual men. Int J STD AIDS 2009;10:741-4.
3. BASHH National Audit Group. 2009 asymptomatic screening audit, 2010. http://www.bashh.org/groups/national-audit-group (accessed 12 Feb 2010).
4. Ho MK, Lo JYC, Lo ACT, et al. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting. Sex Transm Infect 2009;85:322-5.
5. Van DE, Ieven M, Pattyn S, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture, and three nucleic acid amplification tests. J Clin Microbiol 2001;39:1751-6.
6. British Association for Sexual Health and HIV. Standards for the management of sexually transmitted infections, 2010. http://www.bashh.org/news/ 435-bashh-standards-for-the-management-of-sexually-transmitted-infections (accessed 12 Feb 2010).
7. Meyers D, Wolff T, Gregory K, et al. USPSTF recommendations for STI screening. Am Fam Phys 2008;77:819-24.
8. Manhart LE, Marrazzo JM, Fine DN, et al. Selective testing criteria for gonorrhea among young women screened for chlamydial infection: contribution of race and geographic prevalence. J Infect Dis 2007;196:731-7.
9. Rogers SM, Miller HG, Miller WC, et al. NAAT-identified and self-reported gonorrhea and chlamydial infections: different at-risk population subgroups? Sex Transm Dis 2002;29:588-96.
10. UK Department of Health. High quality care for all, 2008. http://www.dh.gov.uk/dr-consum-dh/groups/dh-digitalassets/@dh/@en/documents/ digitalasset/dh-085828.pdf (accessed 12 Feb 2010).
11. Shahmanesh M, Gayed S, Ashcroft M, et al. Geomapping of chlamydia and gonorrhoea in Birmingham. Sex Transm Infect 2000;76:268-72.
12. Lavelle SJ, Jones KE, Mallinson H, et al. Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay. Sex Transm Infect 2006;82:221-4.
13. Health Protection Agency. Guidance for gonorrhoea testing in England and Wales. Letter from Health Protection Agency, 2010. http://www.hpa.org.uk/web/ HPAwebFile/HPAweb-C/1267550166455 (accessed 26 August 2010).
14. McCartney C, Ison C, Duerden BI. HPA Guidance on Testing for Gonorrhoea withn the NCSP. Health Protection Agency, 2007. http://www.chlamydiascreening. nhs.uk/ps/assets/pdfs/lab/letter-chlamydia-testing.pdf (accessed 26 August 2010).
15. Cook RL, Hutchison SL, Ostergaard L, et al. Systematic review: Noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25. (Pubitemid 40791807)